COVID-19 Case Challenges: Employing Outpatient Antivirals and Addressing Drug‒Drug Interactions
Listen to Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, describe how to optimize outpatient COVID-19 antiviral therapy, discuss how to assess and manage drug-drug interactions with COVID-19 antivirals using available resources, and answer learner’s most pressing questions about this topic.
Decera Clinical Education Infectious Disease Podcast · Renslow Sherer MD, Trinh P. Vu PharmD BCIDP
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss how to optimize the use of COVID-19 antivirals and how to navigate drug-drug interactions between COVID-19 treatments and a patient’s home medications. Their discussion includes:
- Current COVID-19 landscape
- COVID-19 testing and vaccination recommendations
- Treatment guidelines and antiviral options for nonhospitalized adults with COVID-19
- Resources for assessing and managing COVID-19 antiviral-related drug-drug interactions
- Answers to learners’ most pressing questions
Presenters:
Renslow Sherer, MD
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois
Trinh P. Vu, PharmD, BCIDP
Clinical Pharmacy Specialist in Infectious Diseases
Department of Pharmacy
Emory University Hospital Midtown
Atlanta, Georgia
Slideset: https://bit.ly/4c6kwbJ
Downloadable resource:
https://bit.ly/49rofP6
Full program:
https://bit.ly/3P16TR8
Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.